½ÃÀ庸°í¼­
»óǰÄÚµå
1616749

EPA/DHA ¼ººÐ ½ÃÀå ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м®, ¿¹Ãø(2024-2032³â)

EPA/DHA (Omega 3) Ingredients Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 220 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è EPA/DHA(¿À¸Þ°¡ 3) ¼ººÐ ½ÃÀåÀº 2023³â 30¾ï ´Þ·¯·Î Æò°¡µÆ½À´Ï´Ù.

2024³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ 6.5% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀÌ´Â ¿À¸Þ°¡ 3 Áö¹æ»êÀÇ °Ç°­»óÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ¼ÒºñÀÚ ÀνÄÀÌ ³ô¾ÆÁø °ÍÀÌ ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ±â¾÷µé °£ÀÇ Á¦ÈÞ·Î »ý»ê´É·ÂÀÌ °­È­µÇ°í ÀÖ½À´Ï´Ù. ±â´É¼º ½Äǰ ¹× °Ç°­º¸Á¶½Äǰ¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϸ鼭 ½ÃÀåÀÌ Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ¼ÒºñÀÚµéÀÇ °Ç°­¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ °í±Þ ¿À¸Þ°¡ 3 ¼ººÐ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¿À¸Þ°¡ 3 Áö¹æ»ê ½ÃÀåÀº °Ç°­°ú À£ºùÀ» Áß½ÃÇÏ´Â ¼ÒºñÀÚÀÇ Áõ°¡¿¡ ÈûÀÔ¾î Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ƯÈ÷ ½ÉÇ÷°ü À§Çè °¨¼Ò, ÀÎÁö ±â´É Çâ»ó, ¿°Áõ °ü¸® µî ¿À¸Þ°¡ 3 Áö¹æ»êÀÇ °Ç°­ È¿°ú¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ´Ù¾çÇÑ ¿ëµµ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. »ê¾÷Àº Á¦Ç°, °ø±Þ¿ø, ¿ëµµ, Áö¿ªÀ¸·Î ±¸ºÐµË´Ï´Ù. ¸êÄ¡¿Í Á¤¾î¸® ¿ÀÀÏ¿¡ ´ëÇÑ ¼ö¿ä´Â ¿ì¼öÇÑ »ýü ÀÌ¿ë·ü°ú ºñ¿ë È¿À²¼º¿¡ ÈûÀÔ¾î 2024-2032³â ¿¬Æò±Õ 9.2% ÀÌ»óÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, EPA/DHAÀÇ ÁÖ¿ä °ø±Þ¿ø ¿ªÇÒÀ» ÇÏ´Â ¸êÄ¡¿Í Á¤¾î¸®´Â ¿À¸Þ°¡ 3°¡ dzºÎÇÑ ¼ÒÇü Áö¼º ¾î·ù·Î ÃßÃâ¿¡ ÀûÇÕÇÕ´Ï´Ù. ¿À¸Þ°¡ 3¸¦ dzºÎÇÏ°Ô ÇÔÀ¯Çϰí ÀÖ¾î ÃßÃâ¿¡ ÀûÇÕÇÕ´Ï´Ù.

¿À¸Þ°¡ 3 ¼ººÐ ½ÃÀåÀÌ ºü¸£°Ô ¼ºÀåÇÔ¿¡ µû¶ó, »ý»êÀÚµéÀº Ã¥ÀÓ°¨ ÀÖ°Ô Á¶´ÞµÈ Á¦Ç°¿¡ ´ëÇÑ ¼ÒºñÀÚ ¼ö¿ä Áõ°¡¿¡ ºÎÀÀÇϱâ À§ÇØ Áö¼Ó°¡´ÉÇÑ ¾î¾÷ °üÇà°ú ÀÎÁõÀ» Á¡Á¡ ´õ ¸¹ÀÌ Ã¤ÅÃÇϰí ÀÖÀ¸¸ç, 2023³â¿¡´Â ¿µ¾ç º¸ÃæÁ¦ ºÎ¹®ÀÌ EPA/DHA ¼ººÐ ½ÃÀå¿¡¼­ »ó´çÇÑ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ºÎ¹®Àº 2024³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ 6.5% ÀÌ»óÀÇ ¼ºÀå·üÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °Ç°­ ¹× À£ºù ÁõÁø¿¡ ÀÖ¾î °Ç°­º¸Á¶½ÄǰÀÇ ÆíÀǼºÀÌ ÀÌ ºÎ¹®ÀÇ ¿À¸Þ°¡ 3 ¼ººÐ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ƯÈ÷ EPA/DHA º¸ÃæÁ¦´Â ½ÉÇ÷°ü °Ç°­, ÀÎÁö ´É·Â, °üÀý À¯¿¬¼ºÀ» Çâ»ó½Ã۰íÀÚ ÇÏ´Â »ç¶÷µé »çÀÌ¿¡¼­ ³ôÀº ¼ö¿ä¸¦ º¸À̰í ÀÖ½À´Ï´Ù.

½ÃÀå ¹üÀ§
½ÃÀÛ ¿¬µµ 2023³â
¿¹Ãø ¿¬µµ 2024-2032
½ÃÀÛ °¡°Ý 30¾ï ´Þ·¯
¿¹»ó °¡°Ý 54¾ï ´Þ·¯
CAGR 6.5%

2023³â ¾Æ½Ã¾ÆÅÂÆò¾çÀº EPA/DHA ¿ø·á ½ÃÀåÀÇ »ó´ç ºÎºÐÀ» Â÷ÁöÇßÀ¸¸ç, 2032³â¿¡´Â 15¾ï ´Þ·¯ ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀÇ ÁÖ¿ä ¿øµ¿·ÂÀº Áß±¹, ÀϺ», Àεµ¿Í °°Àº ±¹°¡¿¡¼­ ¿À¸Þ°¡ 3ÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁø °ÍÀ» µé ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¸¸¼ºÁúȯÀÇ È®»ê, °¡Ã³ºÐ ¼Òµæ Áõ°¡ ¹× Áß»êÃþ È®´ë¿¡ µû¶ó ¿µ¾ç º¸ÃæÁ¦¿Í ±â´É¼º ½Äǰ ¸ðµÎ¿¡¼­ EPA/DHA ¼ººÐ¿¡ ´ëÇÑ ¼ö¿ä°¡ ´«¿¡ ¶ç°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå »ê¾÷ ÀλçÀÌÆ®

  • »ýÅÂ°è ºÐ¼®
    • ¹ë·ùüÀÎ
    • ÁÖ¿ä Á¦Á¶¾÷ü
    • ½ÃÀå ÁøÃâ ·çÆ®
    • ÁÖ¿ä À¯Åë¾÷ü
      • »õ·Î¿î À¯Åë ä³Î
    • »ê¾÷ ÀüüÀÇ ÀÌÀÍ·ü
  • »ê¾÷¿¡ ´ëÇÑ ¿µÇâ¿äÀÎ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÃÀå °úÁ¦
    • ½ÃÀå ±âȸ
      • ½Å½ÃÀå/¿ëµµ
      • ¼ºÀå °¡´É¼º ºÐ¼®
  • ¿ø·á »óȲ
    • Á¦Á¶ µ¿Çâ
      • ±â¼úÀÇ ÁøÈ­
    • °¡°Ý µ¿Çâ(Áö¿ªº°)(´Þ·¯/Åæ)
      • ºÏ¹Ì
      • À¯·´
      • ¾Æ½Ã¾ÆÅÂÆò¾ç
      • ¶óƾ¾Æ¸Þ¸®Ä«
      • Áßµ¿¡¤¾Æ½Ã¾Æ
  • ±ÔÁ¦¿Í ½ÃÀå¿¡ ´ëÇÑ ¿µÇâ
  • Porters ºÐ¼®
  • PESTEL ºÐ¼®

Á¦4Àå °æÀï ±¸µµ

  • ±â¾÷ Á¡À¯À² ºÐ¼®
  • °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • Àü·« Àü¸Á ¸ÅÆ®¸¯½º

Á¦5Àå ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Á¦Ç°º°, 2021-2032³â

  • ÁÖ¿ä µ¿Çâ
  • EPA
  • DHA

Á¦6Àå ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : °ø±Þ¿øº°, 2021-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ¸êÄ¡/Á¤¾î¸®À¯
  • °í³óÃà
  • Áß³óÃà
  • Àú³óÃà
  • Á¶·ù ¿ÀÀÏ
  • ÂüÄ¡ ¿ÀÀÏ
  • ´ë±¸ °£À¯
  • ¿¬¾î ¿ÀÀÏ
  • Å©¸± ¿ÀÀÏ
  • ¸àÇìÀÌµç ¿ÀÀÏ

Á¦7Àå ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ¿ëµµº°, 2021-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ½ÄÀ̺¸ÃæÁ¦
  • ±â´É¼º ½Äǰ
  • ÀÇ¾à ½Äǰ
  • À¯¾Æ¿ë ½Äǰ
  • ¹Ý·Áµ¿¹°¡¤µ¿¹°¿ë »ç·á
    • ¼ö»ê¾ç½Ä
    • Ãà»ê
    • ¹Ý·Áµ¿¹° »ç·á
  • ±âŸ

Á¦8Àå ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Áö¿ªº°, 2021-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå ±â¾÷ °³¿ä

  • Nordic Naturals Inc
  • BASF SE
  • Koninklijke DSM N.V.
  • Clover Corporation
  • Omega Protein
  • Copeinca ASA
  • Solutex
  • Epax Norway AS
  • Croda International Plc
  • Arista Industries Inc
  • GC Rieber
  • OLVEA
  • Lysi
ksm 24.12.30

The Global EPA/DHA (Omega 3) Ingredients Market was valued at USD 3 billion in 2023. Projections indicate a growth of 6.5% CAGR from 2024 to 2032, primarily fueled by heightened consumer awareness regarding the health advantages of omega-3 fatty acids. Additionally, collaborations among major companies are bolstering production capabilities. The market is witnessing robust growth, largely attributed to the surging demand for functional foods and dietary supplements. With consumers placing a premium on health, the appetite for premium omega-3 ingredients is set to escalate.

This market is on the brink of significant expansion, spurred by a heightened consumer emphasis on health and wellness. The escalating recognition of omega-3 fatty acids' health benefits especially in mitigating cardiovascular risks, bolstering cognitive function, and managing inflammation is propelling their demand across diverse applications. The industry is segmented into product, source, application, and region. Driven by their superior bioavailability and cost-effectiveness, the demand for anchovies and sardine oil is projected to grow at a rate exceeding 9.2% CAGR from 2024 to 2032. Serving as primary sources for EPA/DHA ingredients, anchovies, and sardines, being small oily fish rich in omega-3s, are favored for extraction.

As the omega-3 ingredient market burgeons, producers are increasingly adopting sustainable fishing practices and certifications to cater to the rising consumer demand for responsibly sourced products. In 2023, the dietary supplements segment commanded a notable share of the EPA/DHA ingredients market. Projections suggest this segment will grow at a rate surpassing 6.5% CAGR from 2024 to 2032. The convenience of dietary supplements in promoting health and wellness is driving the demand for omega-3 ingredients in this arena. Notably, EPA/DHA supplements are in high demand among those aiming to enhance cardiovascular health, cognitive abilities, and joint flexibility.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$3 Billion
Forecast Value$5.4 Billion
CAGR6.5%

In 2023, the Asia Pacific held a substantial portion of the EPA/DHA ingredients market. By 2032, it is projected to reach a valuation of USD 1.5 billion. Key drivers of this growth include a rising awareness of omega-3 benefits in nations like China, Japan, and India. Furthermore, as chronic diseases become more prevalent and the middle class expands with increased disposable income, there is a notable uptick in demand for EPA/DHA ingredients in both dietary supplements and functional foods.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculation
  • 1.4 Data sources
    • 1.4.1 Primary
    • 1.4.2 Data Mining Sources
      • 1.4.2.1 Paid sources
      • 1.4.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Value chain
    • 3.1.2 Key manufacturers
    • 3.1.3 Go to market routes
    • 3.1.4 Key distributors
      • 3.1.4.1 New distribution channels
    • 3.1.5 Profit margins across the industry
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
    • 3.2.2 Market challenges
    • 3.2.3 Market opportunities
      • 3.2.3.1 New markets/applications
      • 3.2.3.2 Growth potential analysis
  • 3.3 Raw material landscape
    • 3.3.1 Manufacturing trends
      • 3.3.1.1 Technology evolution
    • 3.3.2 Pricing trend, by Region (USD/Ton)
      • 3.3.2.1 North America
      • 3.3.2.2 Europe
      • 3.3.2.3 Asia Pacific
      • 3.3.2.4 Latin America
      • 3.3.2.5 Middle East & Asia
  • 3.4 Regulations & market impact
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Company market share analysis
  • 4.2 Competitive positioning matrix
  • 4.3 Strategic outlook matrix

Chapter 5 Market Size and Forecast, By Product, 2021-2032 (USD Million, Kilo Tons)

  • 5.1 Key trends
  • 5.2 EPA
  • 5.3 DHA

Chapter 6 Market Size and Forecast, By Source, 2021-2032 (USD Million, Kilo Tons)

  • 6.1 Key trends
  • 6.2 Anchovy/Sardine Oils
  • 6.3 High concentrates
  • 6.4 Medium concentrates
  • 6.5 Low concentrates
  • 6.6 Algae oil
  • 6.7 Tuna oil
  • 6.8 Cod liver oil
  • 6.9 Salmon oil
  • 6.10 Krill oil
  • 6.11 Menhaden oil

Chapter 7 Market Size and Forecast, By Application, 2021-2032 (USD Million, Kilo Tons)

  • 7.1 Key trends
  • 7.2 Dietary supplements
  • 7.3 Functional food
  • 7.4 Pharmaceutical food
  • 7.5 Infant food
  • 7.6 Pet & Animal feed
    • 7.6.1 Aquaculture
    • 7.6.2 Livestock
    • 7.6.3 Pet food
  • 7.7 Others

Chapter 8 Market Size and Forecast, By Region, 2021-2032 (USD Million, Kilo Tons)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 India
    • 8.4.3 Japan
    • 8.4.4 South Korea
    • 8.4.5 Australia
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 MEA
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 South Africa
    • 8.6.4 Rest of MEA

Chapter 9 Company Profiles

  • 9.1 Nordic Naturals Inc
  • 9.2 BASF SE
  • 9.3 Koninklijke DSM N.V.
  • 9.4 Clover Corporation
  • 9.5 Omega Protein
  • 9.6 Copeinca ASA
  • 9.7 Solutex
  • 9.8 Epax Norway AS
  • 9.9 Croda International Plc
  • 9.10 Arista Industries Inc
  • 9.11 GC Rieber
  • 9.12 OLVEA
  • 9.13 Lysi
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦